SGN-40
Published:
A monoclonal antibody that binds to cells that have the CD40 antigen on their surface, including cells from multiple myeloma, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. SGN-40 is being studied in the treatment of cancer. It belongs to the family of drugs called monoclonal antibodies.